Jane Martin
Jane Martin was Acting Chief Executive Officer at Wisdom Tools, Inc., a company that she spun out of Indiana University. She has also been involved in various pro bono investment counseling and fundraising activities, many in association with Indiana University. She has also invested in several local start-ups and venture funds. Before returning to Bloomington, Jane was a General Partner at U.S. Venture Partners, a leading venture capital firm in Silicon Valley. She is a CFA and holds a B.S. in Marketing and Finance from Indiana University.

Matt Harris

Mr. Harris is co-founder and Managing General Partner of Village Ventures. Harris, 32, began his career as a consultant at Bain & Company, Boston, in 1994. In 1995, he signed on as an associate with Bain Capital. At Bain Capital, Harris’ most notable transactions included the $1.1 billion purchase and subsequent sale of a credit-reporting agency, and the $90 million purchase of a medical products distributor. Harris left Bain Capital in 1997 to become the founding managing director of The Berkshires Capital Investors, a venture capital fund chartered to invest in companies in Berkshire County. Under Harris’ leadership, BCI’s first fund of $5 million invested in 12 companies, with 7 successful exits to date. The BCI organization, now a Village Ventures affiliate, has gone on to raise an additional $60 million. At BCI, Harris noted that a number of markets boast the attributes of Berkshire County, namely access to intellectual capital, a high quality of life, and a low cost of doing business. However, these regional niches are traditionally underserved by private equity firms. Village Ventures was created to benefit from the imbalance between supply of and demand for venture capital in these markets. Harris graduated from Williams College in 1994, and now lives in Williamstown, MA. He is active in the business community of Williamstown and Berkshire County, and is involved in many civic organizations. He has served as Chair of Mass Competitive Council for Berkshire County, an economic development initiative sponsored by the governor of Massachusetts, and serves as a Board Member of the John Adams Innovation Institute and a member of the Renewable Energy Industry Support Advisory Board. Matt is a Trustee for the Massachusetts College of Liberal Arts, he is the Vice President of the Board of the Williamstown Theatre Festival and is a founding Board Member and Treasurer of Camp Starfish, a camp for troubled and disadvantaged youth outside Boston, MA. Matt also sits on the corporate boards of Skillview Technologies, Inc, Mindbranch, Inc, FullTurn Entertainment, Inc and BlueTarp, Inc.

Antoine Abdallah Agassi

Antoine Abdallah Agassi joined The State of Tennessee as the Director and Chair of the eHealth Council. Mr. Agassi has over twenty years of experience in Healthcare transaction processing. Most recently, Mr. Agassi served as the Chief Technology Officer and the Chief Operating Officer of Spheris Corporation, a leading healthcare transcription and technology organization. Prior to that Mr. Agassi served as the Executive Vice President and Corporate CIO of WebMD. Previously he was the Senior Vice President and CIO of ENVOY Corporation, a leading healthcare EDI transactions company. Mr. Agassi was also the Vice President of Information Systems at Blue Cross Blue Shield of Utica-Watertown in New York. He serves on a number of committees and boards and is a founding principal of Satchel ventures and Holdings. Mr. Agassi earned his MBA from Syracuse University and his Bachelor of Science degree from the State University of New York.

Bruce J. Boehm

Mr. Boehm is an independent venture capitalist, an advisor to several specialty venture capital funds, and on the adjunct faculty of the Kenan Flagler School of Business at UNC, Chapel Hill. From 1992 to 1996 he created and directed the Masters of Engineering Management Program at the University of Canterbury in Christchurch, New Zealand. Prior to 1992 he was a General Partner of U. S. Venture Partners in Menlo Park, California, with responsibility for a portfolio of approximately 20 health-care and technology investments. Prior to 1982 he was employed by several Silicon Valley and Route 128 companies as an engineer and project manager. Mr. Boehm received a BS from MIT, and an MS and MBA from Stanford University. During his career he has been a director of more than 25 publicly and privately held companies.

David Brautigan, PhD

Dr. Brautigan has been Director of the Center for Cell Signaling and a Professor of Microbiology and Medicine with the University of Virginia School of Medicine since 1994. Prior to his tenure at UVA, he was a Professor of Medical Science at Brown University in Rhode Island for eight years and served as an Associate Professor of Biochemistry at the University of Washington School of Medicine in Seattle, Washington where he was also a Research Fellow in the laboratory of Edmond H. Fischer, Ph.D. In addition to his management, teaching and research schedule, Dr. Brautigan has served and continues service as a consultant and Board member on several corporate and institutional Boards including: as a consultant to Merck Sharp and Dohme Research Laboratories and to Bayer AG; as a member of the Scientific Advisory Board for Kemin Industries, Des Moines, Iowa; as a member of the Public Affairs Advisory Committee for the American Society for Biochemistry and Molecular Biology where he previously served as a Chair for their Human Resources Committee; as a member of the Board of Directors for the Federation of American Societies for Experimental Biology; as a member of the Editorial Advisory Boards for Biochemistry, published by the American Chemical Society, for Cell Motility and Cytoskeleton and for BMC Cell Biology, an on-line access journal. Dr. Brautigan has been involved and continues his work with multiple Study Sections for the National Institute of Health. He has served on multiple boards and committees at the University of Virginia and related community Boards to encourage best practices in research and development, technology transfer and entrepreneurship. Dr. Brautigan has over 160 peer-reviewed publications and manages multiple grants to study the mechanisms of action involved with protein phosphatases. The results of his studies are expected to help understanding of cell adhesion and migration, smooth muscle contractility, morphogenesis during development and how defects in these processes lead to human diseases.

Earl Grossman

Mr. Grossman is President of Northwoods Partners, LLC, a private equity investment group that invests alongside management teams in the purchase of established middle-market service businesses. He is also a Managing Director with WorldStrides, LLC in Virginia and the CEO of The Accent Travel Group, LLC in Philadelphia. Earl’s background also includes 8 years as an investment banker in Chicago and New York with a focus on mergers and acquisitions and private debt and equity financings. He received his BA in math and computer science from Dartmouth College and his MBA from the University of Chicago.

Mark Logan

Mr. Logan is the former Chairman, CEO and President of VISX, Inc. Mr. Logan came to VISX in 1994, and retired in 2001. VISX is the world leader in the manufacture and marketing of laser equipment for use in correcting refractive vision errors (LASIK). VISX was acquired by Advanced Medical Optics in May, 2005.

Previous positions included Chairman and CEO of Insmed Pharmaceuticals, Inc. (1991 – 1994); Principal at McManis Associates (1988 –1991); Executive VP, COO and member of the Board of Directors of Bausch & Lomb (1981 – 1985); Group President at Becton, Dickinson & Co. (1975 – 1981); and senior management positions at Wyeth, Inc., including President & General Manager of Wyeth Mexico (1967 – 1975).

He currently serves on the board of directors of two public companies: Abgenix, Inc., Freemont, CA, (since 1997) where he chairs the Compensation Committee and is a member of the Audit Committee. VIVUS, Inc., Mountain View, CA (since 1999) where he chairs the Audit Committee and is a member of the Compensation Committee. Previous public boards: Somnus Medical Technologies, Inc, Sunnyvale, CA (Acquired); Align Technology, Inc., Santa Clara, CA; Imagyn Medical Technologies, Inc., Laguna Niguel, CA (Acquired); Bausch & Lomb, Rochester, NY.

Current non-public board positions include: Board of Directors, University of Virginia Heart & Vascular Center; Trustee and Member of the Executive Committee of The Southern Environmental Law Center; Board of Directors, Public Policy Virginia; and Member of the Investment Committee of Tall Oaks Capital, LLC.

Education: Hiram College, BA, 1960; New York University, Woodrow Wilson Fellow, 1961; Harvard Business School, PMD, 1967.

Military: Pilot, US Marine Corps

James C. Powers

Jim Powers is Executive Vice President of Worldwide Business Development and Secretary of PRA International, a leading, publicly traded contract research organization, which designs and implements clinical development programs for pharmaceutical and biopharmaceutical companies worldwide. Mr. Powers joined PRA in September 1988 as Vice President and General Manager. He became President of North American Operations in January 1992 and the held the position until moving into his current role in 1996.

Mr. Powers was instrumental in the growth and success of PRA. He is responsible for managing PRA’s global sales and marketing efforts. Mr. Powers is involved actively in developing long term, strategic relationships with clients.

Prior to joining the Company, Mr. Powers was Vice President at University Technology Corporation from 1985 to 1988, where he was responsible for identifying and managing technology start-up businesses. While at University Technology Corporation, he served as Vice President of EndoTox Corporation, an endocrine and drug testing laboratory in Richmond, Virginia. From 1973 to 1985, Mr. Powers held positions of increasing responsibility at Clairol, Inc., a leading hair care products company. Mr. Powers received a Bachelor of Science in Administration and Management Science from Carnegie-Mellon University.

W. McIlwaine Thompson, Jr.

Mr. Thompson, who is of counsel to the law firm of Woods Rogers PLC, specializes in corporate law representing companies in diverse fields, including biotechnology, information technology, and oil and gas exploration. He is Secretary of Insmed Incorporated, a publicly-traded biotechnology company. He is also a member of the Boards of Mestena Inc., an oil and gas exploration company, and Foundation Energy Management, LLC, which acquires producing oil and gas properties. Mr. Thompson is a member of the Heart and Vascular Center Advisory Board at the University of Virginia Medical School and a member of the Board and immediate past Chairman of the Board of UVA’s Curry School of Education Foundation. Mr. Thompson graduated from Yale College in 1969 and the University of Virginia Law School in 1972.